Background: Uterine fibroid (Leiomyomata) is the most common benign tumor in women. It may be solitary, multiple or diffuse, there is a genetic predisposition to the development of leiomyomata.
Objective: To evaluate the safety and efficacy of myomectomy during cesarean section.
Patients and methods: A case control study was conducted in Obstetrics and Gynecology Department, Faculty of Medicine, Al-Azhar University during the period from 1st of December 2018 to 30th November 2019. It included 80 patients who underwent to cesarean section. The patients were divided into two equal groups: Group A had been undergone to myomectomy during cesarean section while control group B were only cesarean section without any other intervention.
Results: Pre/postoperative hemoglobin was slightly lower in group A compared to group B without statistically significant difference and no significant change in hemoglobin value from preoperative to postoperative. Mean blood loss was slightly higher in group A compared to group B without significant difference. Meanwhile, blood transfusion and postoperative fever were more frequent in group A but without significant difference. BMI, myomectomy with CS, and fibroid size 3 -6 & > 6 cm were found to significant risk factors for hemorrhage.
Conclusion: Myomectomy during caesarean section was safe and cost effective as it avoid possible fibroid removal at later age.